SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Weiwei Liu, Yao Hu, Yannan Yang, Tingting Hu, Xinyu Wang, Comparison of two immunoassays for quantification of hepatitis B surface antigen in Chinese patients with concomitant hepatitis B surface antigen and hepatitis B surface antibodies, Archives of Virology, 2015, 160, 1, 191

    CrossRef

  2. 2
    Lin Cheng, Xiaowen Sun, Shun Tan, Wenting Tan, Yunjie Dan, Yi Zhou, Qing Mao, Guohong Deng, Effect of HLA-DP and IL28B gene polymorphisms on response to interferon treatment in hepatitis B e-antigen seropositive chronic hepatitis B patients, Hepatology Research, 2014, 44, 9
  3. 3
    Sung Soo Ahn, Young Eun Chon, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park, Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort, Clinical and Molecular Hepatology, 2014, 20, 3, 261

    CrossRef

  4. 4
    Christine L. Ahrens, Edward M. Manno, Neurologic Aspects of Systemic Disease Part II, 2014,

    CrossRef

  5. You have free access to this content5
    Yun-Fan Liaw, Impact of therapy on the outcome of chronic hepatitis B, Liver International, 2013, 33,
  6. 6
    Tarik Asselah, Patrick Marcellin, Long-term Results of Treatment with Nucleoside and Nucleotide Analogues (Entecavir and Tenofovir) for Chronic Hepatitis B, Clinics in Liver Disease, 2013, 17, 3, 445

    CrossRef

  7. 7
    M. Liu, H. Cai, W. Yi, Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy, Journal of Viral Hepatitis, 2013, 20,
  8. 8
    Raymund R. Razonable, Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus, Mayo Clinic Proceedings, 2011, 86, 10, 1009

    CrossRef

  9. 9
    Wei Wang, Yang Liu, Xiangyang Zu, Rui Jin, Gengfu Xiao, Blocking peptides against HBV: PreS1 protein selected from a phage display library, Biochemical and Biophysical Research Communications, 2011, 412, 4, 633

    CrossRef

  10. 10
    Murat Sayan, Sila Cetin Akhan, Omer Senturk, Frequency and Mutation Patterns of Resistance in Patients with Chronic Hepatitis B Infection Treated with Nucleos(t)ide Analogs in Add-On and Switch Strategies, Hepatitis Monthly, 2011, 11, 10, 835

    CrossRef

  11. You have free access to this content11
    Yun-Fan Liaw, Impact of hepatitis B therapy on the long-term outcome of liver disease, Liver International, 2011, 31,
  12. You have free access to this content12
    Rami Moucari, Patrick Marcellin, Quantification of hepatitis B surface antigen: a new concept for the management of chronic hepatitis B, Liver International, 2011, 31,
  13. 13
    L.-C. Wang, E.-Q. Chen, J. Cao, L. Liu, J.-R. Wang, B.-J. Lei, H. Tang, Combination of Lamivudine and adefovir therapy in HBeAg-positive chronic hepatitis B patients with poor response to adefovir monotherapy, Journal of Viral Hepatitis, 2010, 17, 3
  14. 14
    Jia Liu, Yan Yang, Bin Hu, Zhi-yong Ma, Hong-ping Huang, Yuan Yu, Shen-pei Liu, Meng-ji Lu, Dong-liang Yang, Development of HBsAg-binding aptamers that bind HepG2.2.15 cells via HBV surface antigen, Virologica Sinica, 2010, 25, 1, 27

    CrossRef

  15. 15
    Dorothy M. Agdamag, Seiji Kageyama, Prisca S. Leaño, Rontgene M. Solante, Elizabeth F. Telan, Ernesto R. Que, Hiroshi Ichimura, Prediction of response to treatment of chronic hepatitis B with pegylated interferon in the Philippines, Journal of Medical Virology, 2010, 82, 2
  16. 16
    Martin Potter, Marina B Klein, Co-infections and co-therapies: treatment of HIV in the presence of hepatitis C and hepatitis B, HIV Therapy, 2009, 3, 2, 189

    CrossRef

  17. 17
    Ya Zhao, Yinghui Li, Jun Liu, Zhongxiang Liu, Yuxiao Huang, Junchuan Lei, Shumei Li, Caifang Xue, Adenoviral-vector mediated transfer of HBV-targeted ribonuclease can inhibit HBV replication in vivo, Biochemical and Biophysical Research Communications, 2008, 371, 3, 541

    CrossRef

  18. 18
    Tarik Asselah, Olivier Lada, Rami Moucari, Patrick Marcellin, Clevudine: a promising therapy for the treatment of chronic hepatitis B, Expert Opinion on Investigational Drugs, 2008, 17, 12, 1963

    CrossRef

  19. 19
    Laurence Lacey, Rong-Nan Chien, Wan-Long Chuang, Raoh-Fang Pwu, Economic evaluation of chronic hepatitis B treatments in Taiwan, Journal of Gastroenterology and Hepatology, 2008, 23, 4
  20. 20
    Emanuele Pontali, Franco Ferrari, Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus, International Journal of Prisoner Health, 2008, 4, 2, 77

    CrossRef

  21. 21
    P. Marcellin, T. Asselah, O. Lada, Traitement « à la carte » de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2008, 32, 1, S1

    CrossRef

  22. 22
    W.-H. Wen, W.-J. Qin, H. Gao, J. Zhao, L.-T. Jia, Q.-H. Liao, Y.-L. Meng, B.-Q. Jin, L.-B. Yao, S.-Y. Chen, A.-G. Yang, An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells, Journal of Viral Hepatitis, 2007, 14, 7
  23. 23
    Margarita Pardo, Javier Bartolomé, Vicente Carreño, Current Therapy of Chronic Hepatitis B, Archives of Medical Research, 2007, 38, 6, 661

    CrossRef

  24. 24
    Howard C. Thomas, Hepatitis B and D, Medicine, 2007, 35, 1, 39

    CrossRef

  25. 25
    Dan Rudin, Sooraj M. Shah, Alexander Kiss, Robert V. Wetz, Vincent M. Sottile, Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials, Liver International, 2007, 27, 9
  26. 26
    Tarik Asselah, Olivier Lada, Rami Moucari, Michèle Martinot, Nathalie Boyer, Patrick Marcellin, Interferon Therapy for Chronic Hepatitis B, Clinics in Liver Disease, 2007, 11, 4, 839

    CrossRef

  27. 27
    Dan Rudin, Lamivudine and interferon versus lamivudine monotherapy for HBeAg-Positive hepatitis B treatment: A meta-analysis of randomized, controlled trials, Advances in Therapy, 2007, 24, 4, 784

    CrossRef

  28. 28
    Helen M. Chun, Michael L. Landrum, Liver-Related Complications in HIV-Infected Individuals, Infectious Diseases in Clinical Practice, 2007, 15, 1, 38

    CrossRef

  29. 29
    L. F. Lacey, E. Gane, The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore, Journal of Viral Hepatitis, 2007, 14, 11
  30. 30
    Patrick Marcellin, Olivier Lada, Tarik Asselah, Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine, Hepatology Research, 2007, 37,
  31. 31
    Rafik Samuel, Robert Bettiker, Byungse Suh, Antiretroviral therapy 2006: Pharmacology, applications, and special situations, Archives of Pharmacal Research, 2006, 29, 6, 431

    CrossRef

  32. 32
    Christian Müller, Chronic Hepatitis B and C – current treatment and future therapeutic prospects, Wiener Medizinische Wochenschrift, 2006, 156, 13-14, 391

    CrossRef

  33. 33
    A. Mas, Entecavir, Gastroenterología y Hepatología, 2006, 29, 41

    CrossRef

  34. 34
    Joseph F. Perz, Gregory L. Armstrong, Leigh A. Farrington, Yvan J.F. Hutin, Beth P. Bell, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, Journal of Hepatology, 2006, 45, 4, 529

    CrossRef

  35. 35
    Vincent Soriano, Marina Nuñez, Julie Sheldon, Belen Ramos, Javier Garcia-Samaniego, Luz Martín-Carbonero, Ivana Maida, Juan Gonzalez-Lahoz, Complications in treating chronic hepatitis B in patients with HIV, Expert Opinion on Pharmacotherapy, 2005, 6, 16, 2831

    CrossRef

  36. 36
    Robert G. Gish, Current Treatment and Future Directions in the Management of Chronic Hepatitis B Viral Infection, Clinics in Liver Disease, 2005, 9, 4, 541

    CrossRef

  37. 37
    Tarik Asselah, Olivier Lada, Rami Moucari, Patrick Marcellin, Chronic hepatitis B,
  38. 38
    Khalid Mumtaz, Umair Syed Ahmed, Nadeem F Zuberi, Sumaira Salamat, Wasim Jafri, Lamivudine during pregnancy for preventing hepatitis B virus infection in newborns, The Cochrane Library,
  39. 39
    Khalid Mumtaz, Amna Subhan, Saeed Hamid, Wasim Jafri, Lamivudine for chronic hepatitis B in adults, The Cochrane Library,
  40. 40
    Khalid Mumtaz, Saeed Hamid, Wasim Jafri, Pegylated interferon for chronic hepatitis B, The Cochrane Library,